These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30191636)

  • 21. WP1130 increases doxorubicin sensitivity in hepatocellular carcinoma cells through usp9x-dependent p53 degradation.
    Liu H; Chen W; Liang C; Chen BW; Zhi X; Zhang S; Zheng X; Bai X; Liang T
    Cancer Lett; 2015 Jun; 361(2):218-25. PubMed ID: 25749422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KIF20B Correlates with LUAD Progression and Is an Independent Risk Factor.
    Yang J; Xu L; Han X
    Crit Rev Eukaryot Gene Expr; 2024; 34(3):49-59. PubMed ID: 38305288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The vertebrate-specific Kinesin-6, Kif20b, is required for normal cytokinesis of polarized cortical stem cells and cerebral cortex size.
    Janisch KM; Vock VM; Fleming MS; Shrestha A; Grimsley-Myers CM; Rasoul BA; Neale SA; Cupp TD; Kinchen JM; Liem KF; Dwyer ND
    Development; 2013 Dec; 140(23):4672-82. PubMed ID: 24173802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combretastatin A-1 phosphate, a microtubule inhibitor, acts on both hepatocellular carcinoma cells and tumor-associated macrophages by inhibiting the Wnt/β-catenin pathway.
    Mao J; Wang D; Wang Z; Tian W; Li X; Duan J; Wang Y; Yang H; You L; Cheng Y; Bian J; Chen Z; Yang Y
    Cancer Lett; 2016 Sep; 380(1):134-43. PubMed ID: 27349166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of MEK suppresses hepatocellular carcinoma growth through independent MYC and BIM regulation.
    Zhou X; Zhu A; Gu X; Xie G
    Cell Oncol (Dordr); 2019 Jun; 42(3):369-380. PubMed ID: 30788663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. USP7 Regulates Cytokinesis through FBXO38 and KIF20B.
    Georges A; Coyaud E; Marcon E; Greenblatt J; Raught B; Frappier L
    Sci Rep; 2019 Feb; 9(1):2724. PubMed ID: 30804394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inter-regulation of IGFBP1 and FOXO3a unveils novel mechanism in ursolic acid-inhibited growth of hepatocellular carcinoma cells.
    Yang LJ; Tang Q; Wu J; Chen Y; Zheng F; Dai Z; Hann SS
    J Exp Clin Cancer Res; 2016 Mar; 35():59. PubMed ID: 27036874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1.
    Wei JC; Meng FD; Qu K; Wang ZX; Wu QF; Zhang LQ; Pang Q; Liu C
    Acta Pharmacol Sin; 2015 Feb; 36(2):241-51. PubMed ID: 25557114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of p53R2 gene expression with specific siRNA sensitizes HepG2 cells to doxorubicin.
    Azimi A; Majidinia M; Shafiei-Irannejad V; Jahanban-Esfahlan R; Ahmadi Y; Karimian A; Mir SM; Karami H; Yousefi B
    Gene; 2018 Feb; 642():249-255. PubMed ID: 29126924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrantly activated Gli2-KIF20A axis is crucial for growth of hepatocellular carcinoma and predicts poor prognosis.
    Shi C; Huang D; Lu N; Chen D; Zhang M; Yan Y; Deng L; Lu Q; Lu H; Luo S
    Oncotarget; 2016 May; 7(18):26206-19. PubMed ID: 27036048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GTSE1 promotes cell migration and invasion by regulating EMT in hepatocellular carcinoma and is associated with poor prognosis.
    Wu X; Wang H; Lian Y; Chen L; Gu L; Wang J; Huang Y; Deng M; Gao Z; Huang Y
    Sci Rep; 2017 Jul; 7(1):5129. PubMed ID: 28698581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinesin family member 15 promotes cancer stem cell phenotype and malignancy via reactive oxygen species imbalance in hepatocellular carcinoma.
    Li Q; Qiu J; Yang H; Sun G; Hu Y; Zhu D; Deng Z; Wang X; Tang J; Jiang R
    Cancer Lett; 2020 Jul; 482():112-125. PubMed ID: 31733289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tunicamycin inhibits cell proliferation and migration in hepatocellular carcinoma through suppression of CD44s and the ERK1/2 pathway.
    Hou H; Ge C; Sun H; Li H; Li J; Tian H
    Cancer Sci; 2018 Apr; 109(4):1088-1100. PubMed ID: 29377347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2.
    Xu D; Jin J; Yu H; Zhao Z; Ma D; Zhang C; Jiang H
    J Exp Clin Cancer Res; 2017 Mar; 36(1):44. PubMed ID: 28320429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of kinesin family member 4A enhanced cell proliferation via activation of Akt signaling and predicted a poor prognosis in hepatocellular carcinoma.
    Huang Y; Wang H; Lian Y; Wu X; Zhou L; Wang J; Deng M; Huang Y
    Cell Death Dis; 2018 Feb; 9(2):141. PubMed ID: 29396392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COH-203, a novel microtubule inhibitor, exhibits potent anti-tumor activity via p53-dependent senescence in hepatocellular carcinoma.
    Qi H; Zuo DY; Bai ZS; Xu JW; Li ZQ; Shen QR; Wang ZW; Zhang WG; Wu YL
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):262-8. PubMed ID: 25449279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma.
    Augello G; Emma MR; Cusimano A; Azzolina A; Mongiovì S; Puleio R; Cassata G; Gulino A; Belmonte B; Gramignoli R; Strom SC; McCubrey JA; Montalto G; Cervello M
    Int J Cancer; 2019 May; 144(10):2613-2624. PubMed ID: 30488605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound.
    Hu Z; Lv G; Li Y; Li E; Li H; Zhou Q; Yang B; Cao W
    J Exp Clin Cancer Res; 2016 Apr; 35():71. PubMed ID: 27102814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.